The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract
Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney
On the other hand, PUFAs, especially arachidonic acid (AA) and adrenic acid (AdA), promote lipid peroxidation under various pathophysiological contexts (Doll et al., 2017)
Additionally, cases with lobar ICH were more likely to receive corticosteroids combined with immunosuppressants (OR 24, p = 0.006)
True rejection is rare but may manifest as resistance due to antibody formation